Effects of different corticosteroids on the development of osteonecrosis in rabbits

被引:33
作者
Miyanishi, K
Yamamoto, T
Irisa, T
Motomura, G
Jingushi, S
Sueishi, K
Iwamoto, Y
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Pathol, Div Pathophysiol & Expt Pathol, Fukuoka 8128582, Japan
基金
日本学术振兴会;
关键词
osteonecrosis; corticosteroid; rabbit; hip;
D O I
10.1093/rheumatology/keh505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Osteonecrosis (ON) of the femoral head is a devastating complication occurring in patients receiving corticosteroid treatment. This study examined the effect of three corticosteroids on the development of ON in rabbits. Methods. Thirty-nine rabbits were injected once intramuscularly with either 25 mg/kg prednisolone sodium succinate (PSL; 13 rabbits), 20 mg/kg methylprednisolone acetate (MPSL; 13 rabbits) or 20 mg/kg triamcinolone acetonide (TR; 13 rabbits). Four weeks after corticosteroid injection, the bilateral femora and humeri were examined histopathologically for the presence of ON. Haematological examinations were performed before and after corticosteroid injection. Results. MPSL treatment (17/26 proximal femora, 65%) significantly increased ON incidence in the proximal femora compared with the levels seen after TR (4/26, 15%) or PSL (3/26, 12%) treatment (P<0.01). Although not significantly increased in comparison with rabbits receiving PSL treatment (1/26 proximal humeri, 4%), ON incidence within the proximal humeri was significantly increased in MPSL-treated rabbits (6/26, 23%) in comparison with those seen in rabbits receiving TR (0/26, 0%) treatment (P<0.05). Serum levels of cholesterol, triglyceride and free fatty acid were significantly higher 1, 2 and 4 weeks after corticosteroid treatment in rabbits treated with MPSL relative to rabbits receiving TR and rabbits with PSL treatment (P<0.05). Conclusions. MPSL treatment significantly increased ON incidence in rabbits over levels seen after TR or PSL treatment.
引用
收藏
页码:332 / 336
页数:5
相关论文
共 30 条
[1]   DOES CORTICOSTEROID-THERAPY AFFECT THE SURVIVAL OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALBERT, DA ;
HADLER, NM ;
ROPES, MW .
ARTHRITIS AND RHEUMATISM, 1979, 22 (09) :945-953
[2]  
ARLET J, 1984, BONE CIRCULATION, P296
[3]   Intravenous pulses of methylprednisolone for systemic lupus erythematosus [J].
Badsha, H ;
Edwards, CJ .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2003, 32 (06) :370-377
[4]  
BOSKEY AL, 1983, CLIN ORTHOP RELAT R, P289
[5]  
Doggrell S A, 2001, Expert Opin Pharmacother, V2, P1177, DOI 10.1517/14656566.2.7.1177
[6]   REALISTIC GUIDELINES OF CORTICOSTEROID-THERAPY IN RHEUMATIC DISEASE [J].
GARBER, EK ;
FAN, PT ;
BLUESTONE, R .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1981, 11 (02) :231-256
[7]  
GLUECK CJ, 2001, CLIN ORTHOP RELAT R, V386, P19
[8]  
JONES JP, 1993, CLIN ORTHOP RELAT R, V292, P294
[9]  
Jones LC, 2003, J RHEUMATOL, V30, P783
[10]  
Lieberman Jay R, 2003, Instr Course Lect, V52, P337